Jiri Zavadil
- Circulating free DNA concentration is an independent prognostic biomarker in lung cancerBy Claire Tissot, Anne-Claire Toffart, Stéphanie Villar, Pierre-Jean Souquet, Patrick Merle, Denis Moro-Sibilot, Maurice Pérol, Jiri Zavadil, Christian Brambilla, Magali Olivier and Sébastien CouraudArticle | Published in 2015 in European Respiratory JournalClaire Tissot1Department of Acute Respiratory Medicine and Thoracic Oncology Department, Lyon Sud Hospital and Lyon University Cancer Institute, Lyon University Hospital, Pierre Bénite, France2International Agency for Research on Cancer, Molecular Mechanisms and Biomarkers Group, Lyon, FranceAnne-Claire Toffart3Université Grenoble 1, INSERM, U 823, Institut A Bonniot, Université J Fourier, La Tronche, France4Thoracic Oncology Unit, Teaching Hospital A Michallon, Grenoble, FranceStéphanie Villar2International Agency for Research on Cancer, Molecular Mechanisms and Biomarkers Group, Lyon, FrancePierre-Jean Souquet1Department of Acute Respiratory Medicine and Thoracic Oncology Department, Lyon Sud Hospital and Lyon University Cancer Institute, Lyon University Hospital, Pierre Bénite, FrancePatrick Merle5Thoracic Oncology Unit, Clermont-Ferrand University Hospital, Clermont-Ferrand, FranceDenis Moro-Sibilot3Université Grenoble 1, INSERM, U 823, Institut A Bonniot, Université J Fourier, La Tronche, France4Thoracic Oncology Unit, Teaching Hospital A Michallon, Grenoble, FranceMaurice Pérol6Thoracic Oncology Unit, Lyon Cancer Centre Léon Bérard, Lyon, FranceJiri Zavadil2International Agency for Research on Cancer, Molecular Mechanisms and Biomarkers Group, Lyon, FranceChristian Brambilla3Université Grenoble 1, INSERM, U 823, Institut A Bonniot, Université J Fourier, La Tronche, France4Thoracic Oncology Unit, Teaching Hospital A Michallon, Grenoble, FranceMagali Olivier2International Agency for Research on Cancer, Molecular Mechanisms and Biomarkers Group, Lyon, FranceSébastien Couraud1Department of Acute Respiratory Medicine and Thoracic Oncology Department, Lyon Sud Hospital and Lyon University Cancer Institute, Lyon University Hospital, Pierre Bénite, France7EMR 3738 “Therapeutic Targeting in Oncology”, Lyon Sud – Charles Mérieux Faculty of Medicine, Lyon 1 University, Oullins, France
- Circulating free DNA concentration is an independent prognostic biomarker in lung cancerBy Claire Tissot, Anne-Claire Toffart, Stéphanie Villar, Pierre-Jean Souquet, Patrick Merle, Denis Moro-Sibilot, Maurice Pérol, Jiri Zavadil, Christian Brambilla, Magali Olivier and Sébastien CouraudClaire Tissot1Department of Acute Respiratory Medicine and Thoracic Oncology Department, Lyon Sud Hospital and Lyon University Cancer Institute, Lyon University Hospital, Pierre Bénite, France2International Agency for Research on Cancer, Molecular Mechanisms and Biomarkers Group, Lyon, FranceAnne-Claire Toffart3Université Grenoble 1, INSERM, U 823, Institut A Bonniot, Université J Fourier, La Tronche, France4Thoracic Oncology Unit, Teaching Hospital A Michallon, Grenoble, FranceStéphanie Villar2International Agency for Research on Cancer, Molecular Mechanisms and Biomarkers Group, Lyon, FrancePierre-Jean Souquet1Department of Acute Respiratory Medicine and Thoracic Oncology Department, Lyon Sud Hospital and Lyon University Cancer Institute, Lyon University Hospital, Pierre Bénite, FrancePatrick Merle5Thoracic Oncology Unit, Clermont-Ferrand University Hospital, Clermont-Ferrand, FranceDenis Moro-Sibilot3Université Grenoble 1, INSERM, U 823, Institut A Bonniot, Université J Fourier, La Tronche, France4Thoracic Oncology Unit, Teaching Hospital A Michallon, Grenoble, FranceMaurice Pérol6Thoracic Oncology Unit, Lyon Cancer Centre Léon Bérard, Lyon, FranceJiri Zavadil2International Agency for Research on Cancer, Molecular Mechanisms and Biomarkers Group, Lyon, FranceChristian Brambilla3Université Grenoble 1, INSERM, U 823, Institut A Bonniot, Université J Fourier, La Tronche, France4Thoracic Oncology Unit, Teaching Hospital A Michallon, Grenoble, FranceMagali Olivier2International Agency for Research on Cancer, Molecular Mechanisms and Biomarkers Group, Lyon, FranceSébastien Couraud1Department of Acute Respiratory Medicine and Thoracic Oncology Department, Lyon Sud Hospital and Lyon University Cancer Institute, Lyon University Hospital, Pierre Bénite, France7EMR 3738 “Therapeutic Targeting in Oncology”, Lyon Sud – Charles Mérieux Faculty of Medicine, Lyon 1 University, Oullins, France
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.